AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
Stock Information for AIM ImmunoTech Inc.
Loading
Please wait while we load your information from QuoteMedia.